• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS TRANSFEMORAL BALLOON CATHETER; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS TRANSFEMORAL BALLOON CATHETER; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9350BC23
Device Problems Burst Container or Vessel (1074); Device Operates Differently Than Expected (2913)
Patient Problems Vascular Dissection (3160); Device Embedded In Tissue or Plaque (3165)
Event Date 12/01/2015
Event Type  Injury  
Manufacturer Narrative
Investigation of this event is ongoing.
 
Event Description
During a transfemoral tavr procedure, while performing a bav with a 23mmx4cm edwards transcatheter balloon catheter, the balloon ruptured.The physician was unable to remove the balloon from the sheath.When the balloon was eventually removed, it had become separated and balloon material remained in the patient.There also appeared to be some type of separation of the inner and outer portions of the balloon catheter.A portion remained fixed to the wire, while a portion was removed.Essentially resulting in 3 separate pieces to the balloon.The outer catheter, inner catheter gripping the wire, and the balloon tip / balloon material that remained in the patient.The balloon material that remained in the patient was located in the left common iliac and external iliac and was jailed by 3 covered stents.Per additional investigation of this event, the balloon ruptured during inflation.The physician was unable to fully inflate due to heavy, severe, and bulky annular calcification.There were no abnormalities noted for the bav balloon during preparation or sizing of balloon.There was no difficulty noted when inserting the bav through the sheath.During balloon removal the balloon catheter became separated.The inner portion that travels on the wire remained on the wire while the outer position that is gripped by the physician/tech was removed.The outer portion of the balloon catheter was removed.The inner lumen of the balloon catheter became "glued" to the wire.They attempted to snare the wire tip from the opposite side in an effort to remove it, with balloon material still on it, from the opposite groin.This effort failed.The wire was cut, the e-sheath was removed, and a new 14fr cook sheath was inserted.Additional attempts to remove the balloon were made without success.Eventually the wire and inner balloon catheter were removed., the patient was extubated the following day.2 days post-op the patient was reported as doing well.The patient did have multiple perforation in the right common iliac, external iliac, and right common femoral, the opposite side where the balloon material became lodged.The patient received blood transfusions.The physician indicated the ruptured balloon, having "wings", would not re-enter the e-sheath.There appeared to not be any volume in the balloon.There was no damage to esheath.The distal tip of the balloon separated while attempting to remove the bav.
 
Manufacturer Narrative
The complaint device was not returned to edwards lifesciences for evaluation.Due to the device (or applicable photo/video, relevant to the reported event) not being returned for evaluation, the complaints of ¿balloon ¿ burst,¿ ¿balloon catheter ¿ withdrawal difficulty ¿ through sheath,¿ and ¿distal tip ¿ separated¿ were unable to be confirmed.Without the device returned for evaluation, functional testing and dimensional analysis were unable to be performed.As noted in the results and findings section, the complaint history and manufacturing mitigation analysis did not indicate that a manufacturing non-conformance was the likely cause of the customer complaint.During manufacturing, the bav is 100% leak tested for any leak paths in the balloon inflation lumen.The balloon is molded and inspected, and inspections are in place for visual non-conformances (foreign matter, impurities, deformation and fish eyes), and double wall thickness dimensions.In addition, samples are destructively tested on the balloon component work order and the bav assembly work order for burst pressure.The inspections during manufacturing support that it is unlikely that a manufacturing non-conformance was the cause of the complaint.The preparation manual and ifu procedure indicated that balloon burst is a potential adverse event when the bav is used.The case file also indicates that the patient had bulky leaflet calcification, which likely contributed to the balloon burst.Once the balloon was burst, the shape of the burst balloon likely contributed to withdrawal difficulties through the esheath, which likely resulted in the distal tip and pieces of the balloon separating from the rest of the catheter by means of withdrawal force utilized during retrieval attempts.The case notes state that the minimal lumen diameter of the access vessel was 5.5mm, and the ifu indicates to use caution in vessels with less than 5.5mm mld.Without functional testing and dimensional analysis engineering is unable to determine the root cause of the failure modes ¿balloon ¿ burst,¿ ¿balloon catheter ¿ withdrawal difficulty ¿ through sheath,¿ and ¿distal tip ¿ separated.¿ the ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.Since no manufacturing non-conformances or ifu/training inadequacies were identified corrective or preventative actions are not required.
 
Manufacturer Narrative
This report have been updated with the correct lot number, expiration and manufacturing dates for the complaint device.A device history record (dhr) review for the bav showed the device met specifications prior to distribution.There were no non-conformances that could have contributed to the complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS TRANSFEMORAL BALLOON CATHETER
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
frances preston
1 edwards way
irvine, CA 92614
9492505190
MDR Report Key5328940
MDR Text Key34428100
Report Number2015691-2015-03572
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100041
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 12/01/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/07/2017
Device Model Number9350BC23
Device Lot Number60195279
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/01/2015
Initial Date FDA Received12/28/2015
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received02/04/2016
02/04/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/15/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
-
-